CZMWF
Carl Zeiss Meditec AG
Set alert
- YTD
- -19.92%
- 1 year
- -26.97%
- Open
- 32.76
- Prev close
- 39.00
- Mkt cap
- 3.41B
- Vol
- 150
- Avg vol
- 66
- EPS
- 1.62
- P/E
- 24.07
More statistics
- Low
- 32.76
- High
- 32.76
- Earnings
- Dec 10, 2026
News
3 days ago seekingalpha.com
Carl Zeiss Meditec: Why The Market Is Finally Recognizing The Recovery
Carl Zeiss Meditec has rebounded nearly 50% from its early 2026 lows, validating the recovery thesis after a severe medtech sector downturn. Despite a 40% earnings decline and 64% share price drop,…
5 months ago seekingalpha.com
Carl Zeiss Meditec AG (CZMWY) Q2 2026 Earnings Call Transcript
Carl Zeiss Meditec AG (CZMWY) Q2 2026 Earnings Call Transcript
5 months ago marketbeat.com
Carl Zeiss Meditec Q2 Earnings Call Highlights
Carl Zeiss Meditec ETR: AFX reported weaker first-half results for fiscal 2025/2026 and outlined a broad restructuring plan aimed at restoring profitability over the next three years, as management…
6 months ago seekingalpha.com
Carl Zeiss Meditec: Bad Optics But With 'Buy' Potential
Carl Zeiss Meditec AG is rated a "Buy" despite recent operational weakness and geopolitical headwinds, especially in Asia-Pacific and North America. Sales declined 4.8% in Q1, with margin compression…
8 months ago seekingalpha.com
Carl Zeiss Meditec AG (CZMWY) Q1 2026 Earnings Call Transcript
Carl Zeiss Meditec AG (CZMWY) Q1 2026 Earnings Call Transcript
9 months ago seekingalpha.com
Carl Zeiss Meditec: Why This Company Is A Good Choice For 2026
Carl Zeiss Meditec is rated a 'Strong Buy' with higher share price target, reflecting significant undervaluation and robust fundamentals. The company achieved over €2.2B in revenue (+7.5% YoY),…
9 months ago seekingalpha.com
Invesco Global Opportunities Fund Q3 2025 Performance Review
Invesco Global Opportunities Fund outperformed most in consumer staples due to stock selection and in real estate due to an underweight allocation. Stock selection in consumer discretionary, IT and…
10 months ago seekingalpha.com
Carl Zeiss Meditec AG (CZMWY) Q4 2025 Earnings Call Transcript
Carl Zeiss Meditec AG (CZMWY) Q4 2025 Earnings Call Transcript
10 months ago seekingalpha.com
Carl Zeiss Meditec AG (CZMWY) Discusses CEO Transition and Management Continuity Strategy Following Code of Conduct Investigation Transcript
Carl Zeiss Meditec AG (CZMWY) Discusses CEO Transition and Management Continuity Strategy Following Code of Conduct Investigation Transcript
11 months ago seekingalpha.com
Invesco International Small-Mid Company Fund Q3 2025 Top Contributors And Detractors
Invesco International Small-Mid Company Fund outperformed most in the real estate and consumer staples sectors due to stock selection. The fund's underweight in real estate also added to relative…
1 year ago seekingalpha.com
Carl Zeiss: The Results After 6M25 Are Encouraging For 2025-2027E
Carl Zeiss Meditec remains a high-quality medtech leader with strong moats in ophthalmic and microsurgery, despite recent margin pressures and Chinese market headwinds. Recent 6M25 results show…
1 year ago seekingalpha.com
Carl Zeiss Meditec AG (CZMWF) Q2 2025 Earnings Call Transcript
Carl Zeiss Meditec AG (OTCPK:CZMWF) Q2 2025 Earnings Conference Call May 13, 2025 4:30 AM ET Company Participants Sebastian Frericks - Director of Investor Relations Markus Weber - President and…
1 year ago seekingalpha.com
Carl Zeiss Meditec: Recovery Seems Clear Enough
Carl Zeiss Meditec remains a "Buy" despite tariff concerns, with a revised price target of €110/share, reflecting geopolitical uncertainties and potential impacts on US-based revenues. The company…
1 year ago seekingalpha.com
Carl Zeiss: Why I Am So Positive
Carl Zeiss Meditec is a high-quality MedTech company with a strong market position, low debt, and significant long-term upside potential despite current macroeconomic challenges. The company's…
2 years ago seekingalpha.com
My 3 Favorite European Stocks To Diversify Your Portfolio
Here is an emphasis on the importance of diversification in US-based investment portfolios to mitigate risks and enhance returns. The recommendation is to focus on sectors with strong growth…
2 years ago seekingalpha.com
Carl Zeiss: Significant Underperformance, Valuation At Multi-Year Lows
Carl Zeiss Meditec has seen a 30%+ decline due to earnings and margin drops, but remains a strong market leader with significant long-term upside. Despite current underperformance, the company's…
2 years ago seekingalpha.com
Carl Zeiss Meditec AG (CZMWF) Q3 2024 Earnings Call Transcript
Carl Zeiss Meditec AG (OTCPK:CZMWF) Q3 2024 Results Conference Call August 6, 2024 4:30 AM ET Company Participants Sebastian Frericks - Director of Investor Relations Markus Weber - CEO & Chairman of…
2 years ago seekingalpha.com
Carl Zeiss Meditec: Slightly Better Valuation, Still A Significant Upside
Carl Zeiss Meditec has underperformed in the medtech field, but its long-term appeal remains intact. The company reported a decline in revenue and margins in the first half of 2023/2024, mainly due…
2 years ago seekingalpha.com
Carl Zeiss Meditec AG (CZMWF) Q2 2024 Earnings Call Transcript
Carl Zeiss Meditec AG (OTCPK:CZMWF) Q2 2024 Earnings Conference Call May 8, 2024 4:30 AM ET Company Participants Sebastian Frericks - Head, IR Markus Weber - CEO Justus Wehmer - CFO Conference Call…
2 years ago seekingalpha.com
Carl Zeiss: We've Seen Outperformance, But I See More Upside Potential
Carl Zeiss Meditec has seen a significant increase in stock performance, up over 29% in less than 3 months. The company has shown strong top-line growth but a decline in EBIT and EBIT margin.…